CARRA Registry

Clinical Trial Title Observational Study for Pediatric Rheumatic Diseases: The CARRA Registry
Trial Status Open to Enrollment
Start Date 06/09/2015
Location legacy-emanuel-medical-center
Trial Type Pediatric Rheumatology
Specific Condition Registry for Pediatric Rheumatic Diseases
Description Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
Eligibility Criteria
Ages Eligible for Study:   2 Years to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Children with pediatric rheumatic diseases enrolled from participating CARRA sites.

Inclusion Criteria:

  1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A).
  2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures.
  3. Subject and/or parent/legal guardian can read either English or Spanish.
  4. Subject and/or parent/legal guardian is willing to be contacted in the future by study staff.
IRB Number 10661
Principal Investigator Daniel Kingsbury, MD
Contact Name Kristin Hickey
Contact Phone 503-413-5447
Contact Fax 503-413-3543
Contact E-Mail